
Andrew Henry Talal MD
Professor of Medicine, University at Buffalo
Join to View Full Profile
875 Ellicott StSte 6090Buffalo, NY 14203
Phone+1 716-888-4738
Fax+1 716-854-1397
Dr. Talal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Andrew Talal, MD, MPH is Professor of Medicine at SUNY Buffalo and a physician-scientist with a particular focus in hepatology. Dr. Talal is an alumnus of The University of Texas Health Science Center at San Antonio, class of 1990. He completed his internal medicine residency at the University of Iowa Hospitals and Clinics and research and clinical fellowships in gastroenterology at the University of North Carolina at Chapel Hill. His research include faciltated telemedicine as a healthcare delivery approach for management of hepatitis C virus infection among people with opioid use disorder. He recently completeed a randomized controlled trial of facilitated telemedicine that illustrated 90.3% hepatitis C virus cure through facilitated telemedicine compared to 39.4% in offsite referral. The study has been honored with a 2025 Top Ten Clinical Research Achievement Award. Dr. Talal serves on the New York State Hepatitis C Elimination Task Force and Guidelines committee. He also serves on the Centers for Medicare & Medicaid Services Technical Expert Panel for electronic clinical quality measures for his expertise in hepatitis C management.
Education & Training
- University of North Carolina HospitalsFellowship, Gastroenterology, 1993 - 1996
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1990 - 1993
- The University of Texas Health Science Center at San AntonioClass of 1990
Certifications & Licensure
- NY State Medical License 1996 - 2027
- NC State Medical License 1993 - 1998
- IA State Medical License 1990 - 1994
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin Start of enrollment: 2002 Feb 01
- Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection Start of enrollment: 2005 Mar 01
- Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV) Start of enrollment: 2009 May 01
- Join now to see all
Publications & Presentations
PubMed
- Considerations for equitable distribution of digital healthcare for people who use drugs.Zoi Papalamprakopoulou, Sotirios Roussos, Elisavet Ntagianta, Vasiliki Triantafyllou, George Kalamitsis
BMC Health Services Research. 2025-04-10 - Breaking the vicious cycle of delayed healthcare seeking for people who use drugs.Zoi Papalamprakopoulou, Elisavet Ntagianta, Vasiliki Triantafyllou, George Kalamitsis, Arpan Dharia
Harm Reduction Journal. 2025-03-05 - Innovative approaches in predicting outcomes for rectal neuroendocrine tumors.Mahmoud Nassar, Bahaaeldin Baraka, Andrew H Talal
World Journal of Gastroenterology. 2025-02-14
Authored Content
- Assessment of Methadone Clinic Staff Attitudes Toward Hepatitis C Evaluation and TreatmentAugust 2010
Press Mentions
- Talal to Be Honored with 2025 Top Ten Clinical Research Achievement AwardFebruary 24th, 2025
- UB Researcher to Receive 2025 Top Ten Clinical Research Achievement Award from the Clinical Research ForumFebruary 18th, 2025
- UB Study Finds Hepatitis C Cured in 90% of Telehealth Patients in Opioid TreatmentJune 18th, 2024
- Join now to see all
Grant Support
- Influence Of Immune Status On HCV Therapy In HIV/HCV Co-Infected IndividualsNational Center For Research Resources2004
- Hepatitis C Viral Dynamics And Cellular Turnover (Fna Substudy)National Center For Research Resources2004
- Viral And Immune Response To Therapy For HIV In The GALTNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- Roferon In Individuals With Hepatitis C And HIV 1National Center For Research Resources2001–2002
- Gastrointestinal Lymphatic Tissue Sampling To Determine Active HIV1 ReplicateNational Center For Research Resources1997–2002
- Roferon In Coinfection With Hepatitis C And HIV 1National Center For Research Resources2000
- Viral And Immune Response To Therapy For HIV In The GALTNational Institute Of Diabetes And Digestive And Kidney Diseases1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: